Ovid Therapeutics Inc (OVID)

전일 마감가:

$3.06

열려 있는:

$3.09

하루 거래량:

9,764

시가총액:

$216.68M

수익:

$391.70K

순이익/손실:

$-52.34M

주가수익비율:

-4.40

EPS:

-0.7

순현금흐름:

$-45.92M

1주 성능:

+2.34%

1개월 성능:

+0.33%

6개월 성능:

-13.31%

1년 성능:

-15.00%

1일 변동 폭

$3.03

$3.12

52주 변동 폭

$2.57

$4.1389

Ovid Therapeutics Inc Stock (OVID) Company Profile

명칭

Ovid Therapeutics Inc

부문

Healthcare (1193)

산업

Biotechnology (685)

전화

646-661-7661

주소

1460 Broadway, Suite 15044, New York, NY

직원

51

트위터

@OvidRx

다음 수익 날짜

2024-05-03

최신 SEC 제출 서류

OVID's Discussions on Twitter

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-04-20	다운그레이드	Cantor Fitzgerald	Buy → Neutral
2021-03-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2020-12-02	다운그레이드	Citigroup	Buy → Neutral
2020-12-02	다운그레이드	JMP Securities	Mkt Outperform → Mkt Perform
2019-09-04	개시	RBC Capital Mkts	Outperform
2018-04-20	개시	Ladenburg Thalmann	Buy

모두보기

Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스

Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks Investment Research

Over $2M Bet On NextNav? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

Benzinga

Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire Inc.

Ligand (LGND) Posts Long-Term Outlook, Updates Portfolio Progress

Zacks Investment Research

Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why

Zacks Investment Research

Ovid Therapeutics Inc (OVID) 재무 분석

Ovid Therapeutics Inc (OVID) 매출 2024

Ovid Therapeutics Inc (OVID) 순이익 2024

Ovid Therapeutics Inc (OVID) 현금흐름 2024

Ovid Therapeutics Inc (OVID) 주당 순이익 2024